ACE I/D gene polymorphisms and polycystic ovary syndrome manifestations-Reference-Cited by-同舟云学术

ACE I/D gene polymorphisms and polycystic ovary syndrome manifestations

Published:2023-10-30 Issue: Volume: Page:
ISSN:2251-6581
Container-title:Journal of Diabetes & Metabolic Disorders
language:en
Short-container-title:J Diabetes Metab Disord

Author:

Asadi Mojgan,Nickhah Klashami Zeynab,Panahi Nekoo^ORCID,Oheb Yodit,Khorasani Sara,Amoli Mahsa M.

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://link.springer.com/content/pdf/10.1007/s40200-023-01335-w.pdf

Reference54 articles.

1. Puurunen J, Piltonen T, Morin-Papunen L, Perheentupa A, Järvelä I, Ruokonen A, et al. Unfavorable hormonal, metabolic, and inflammatory alterations persist after menopause in women with PCOS. J Clin Endocrinol Metab. 2011;96(6):1827–34.

2. Yildiz BO, Bozdag G, Yapici Z, Esinler I, Yarali H. Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria. Hum Reprod (Oxford England). 2012;27(10):3067–73.

3. Naz MSG, Tehrani FR, Majd HA, Ahmadi F, Ozgoli G, Fakari FR et al. The prevalence of polycystic ovary syndrome in adolescents: a systematic review and meta-analysis. 2019;17(8):533.

4. Farhadi-Azar M, Behboudi-Gandevani S, Rahmati M, Mahboobifard F, Khalili Pouya E, Ramezani Tehrani F et al. The prevalence of polycystic ovary syndrome, its phenotypes and cardio-metabolic features in a community sample of Iranian population: Tehran lipid and glucose study. 2022;13:825528.

5. Bani Mohammad M, Majdi Seghinsara A. Polycystic ovary syndrome (PCOS), Diagnostic Criteria, and AMH. Asian Pac J cancer Prevention: APJCP. 2017;18(1):17–21.